Corx Lifesciences And Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.60 M
as on 16-11-2024
- Paid Up Capital ₹ 0.60 M
as on 16-11-2024
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.22 M
as on 16-11-2024
- Revenue 28.51%
(FY 2023)
- Profit -73.59%
(FY 2023)
- Ebitda -19.14%
(FY 2023)
- Net Worth 0.98%
(FY 2023)
- Total Assets 102.05%
(FY 2023)
About Corx Lifesciences And Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.60 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹3.22 M.
Thirumalai Vasantha and Shanmuganathan Shanmuganathan serve as directors at the Company.
- CIN/LLPIN
U24100TN2012PTC085736
- Company No.
085736
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 May 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruchirappalli, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Corx Lifesciences And Pharmaceutical Private Limited offer?
Corx Lifesciences And Pharmaceutical Private Limited offers a wide range of products and services, including Newspaper & Magazine Publishers, Publishing House.
Who are the key members and board of directors at Corx Lifesciences And Pharmaceutical?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Thirumalai Vasantha  | Managing Director | 04-May-2012 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shanmuganathan Shanmuganathan | Director | 12-Dec-2014 | Current |
Financial Performance of Corx Lifesciences And Pharmaceutical.
Corx Lifesciences And Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.51% increase. The company also saw a substantial fall in profitability, with a 73.59% decrease in profit. The company's net worth moved up by a moderate rise of 0.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Corx Lifesciences And Pharmaceutical?
In 2023, Corx Lifesciences And Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Tnb Analytical Laboratory Private LimitedActive 5 years 11 monthsThirumalai Vasantha and Shanmuganathan Shanmuganathan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 19 Dec 2023 | ₹2.22 M | Open |
Idbi Bank Limited Creation Date: 12 Sep 2023 | ₹1.00 M | Open |
How Many Employees Work at Corx Lifesciences And Pharmaceutical?
Unlock and access historical data on people associated with Corx Lifesciences And Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Corx Lifesciences And Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Corx Lifesciences And Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
